Press release
Medroxyprogesterone Acetate Market to Witness a Pronounce Growth During 2016 – 2024 : Persistence Market Research
Medroxyprogesterone Acetate Market: Drivers and Restraints
The medroxyprogesterone acetate market is driven by the increasing need for birth control measure and government initiatives to generate more awareness related to the different contraceptive methods. There are various forecasting initiatives undertaken to understand the demand of Depot medroxyprogesterone acetate (DMPA) as a birth control measure. In January 2015, the Concept Foundation contracted William Davidson Institute (WDI), to understand the demand of DMPA in low income and middle-income countries.
Manufacturers are now trying to develop low-dose injectable of medroxyprogesterone acetate through subcutaneous route so as to lower some of the side effects related to weight gain and metabolic effects.
Sayana Press a three-month, progestin-only injectable contraceptive was approved by the UK authorities in 2015. PATH along with ministries of health in Uganda and Senegal are researching on self-injection of Sayana Press and ways that it could be effective in women. Through the PATH initiatives since 2014, this contraceptive is available in remote locations in Uganda, Senegal, Niger and Burkina Faso. Sayana Press has regulatory approval in Europe and 25 other countries. In 2014, the Children’s Investment Fund Foundation (CIFF), the Bill & Melinda Gates Foundation and Pfizer Inc. decided to offer Sanaya Press to purchasers from 69 countries for US$1 per dose.
The public and the private partners announced in the London Summit to reach poorest countries by 2020 with around 12 million doses of Sayana Press. Injctables has always been a popular contraceptive method in Sub-Saharan Africa and hence the presentation of Sayana Press inj the Uniject device is expected to increase the demand. The all-in-one prefiled injection system improves safety and enhances access through non-clinical channels.
Medroxyprogesterone Acetate Market: Region-wise Outlook
In terms of geography, medroxyprogesterone acetate market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. The presence of major market players, technology advancements and research investments has made North America the dominating region for the cardiac biomarkers market. Moreover, there are many startups who are trying to enter the medroxyprogesterone acetate market with new technologies and more efficacy.
Developing countries are focusing on bringing down the infact and maternal death rates by legalizing the use of injectable contraceptives. One such initiative was taken by Haryana, which became the first state in the country to implement the use of injectable contraceptives. The project would be initiated in nine blocks of the state where the injectable would be available free of costs in all district hospitals, primary health centers and community health centers.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/15688
Medroxyprogesterone Acetate Market: Key Market Participants
Some of the medroxyprogesterone acetate market participants are Pfizer Inc., Fangtong Pharma.Co.Ltd, Gador S.A., Sigma-Aldrich Co. LLC., Teva Pharmaceutical Industries Ltd., Greenstone LLC, Serum Internation Ltd., West-Coast Pharmaceutical, Arrow Pharma Group, and Zuche Pharmaceuticals Pvt. Ltd..
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/15688
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medroxyprogesterone Acetate Market to Witness a Pronounce Growth During 2016 – 2024 : Persistence Market Research here
News-ID: 559869 • Views: …
More Releases from Persistence Market Research
Peptones Market to Reach US$ 512.5 Million by 2032 at 4.6% CAGR | Persistence Ma …
The global peptones market size is valued at US$ 373.7 million in 2025 and is projected to reach US$ 512.5 million by 2032, growing at a CAGR of 4.6% between 2025 and 2032. Market growth is largely supported by expanding biotechnology research activities and increasing pharmaceutical production capabilities. Animal-based peptones remain among the leading product categories due to their extensive use in microbial cultivation. Geographically, North America leads the market…
CMO/CDMO Biotechnology Market to Reach US$168.9 Billion by 2032 at 12.5% CAGR | …
The global CMO/CDMO biotechnology market size is likely to be valued at US$74.0 Billion in 2025 and is estimated to reach US$168.9 Billion by 2032, expanding at a CAGR of 12.5% during 2025-2032. The market is supported by increased investments in bioprocessing technologies, rising clinical trial activities, and growing demand for advanced therapeutic products. Biologics manufacturing services remain the leading segment due to increasing monoclonal antibody production. North America dominates…
Medical Wellness Market to Reach US$3.7 Billion by 2032 at 10.6% CAGR | Persiste …
The global medical wellness market size is expected to reach US$1.8 billion by 2025. It is estimated to reach US$3.7 billion by 2032, growing at a CAGR of 10.6% during the forecast period from 2025 to 2032. Increasing health consciousness, growing corporate wellness adoption, digital health integration, and demand for integrated healthcare experiences are supporting market growth. Wellness centers offering preventive screening, nutrition planning, stress management, and personalized care are…
Acne Treatment Market to Reach US$ 11,825.1 Mn by 2032 at 6.1% CAGR | Persistenc …
The global market for acne treatment is estimated to value at US$ 11,825.1 Mn by the end of 2032 from US$ 7,812.6 Mn recorded in 2025. The market is expected to secure a CAGR of 6.1% in the forthcoming years from 2025 to 2032. Growing incidences of hormonal disorders, increasing urbanization, changing dietary patterns, and rising stress levels are contributing to acne prevalence worldwide. Topical medications continue to represent a…
More Releases for Medroxyprogesterone
Medroxyprogesterone Acetate Production Plant (DPR) 2026: Raw Materials Cost and …
Setting up a medroxyprogesterone acetate (MPA) production plant positions investors at the forefront of one of the most vital and consistently growing segments of the global pharmaceutical active pharmaceutical ingredient (API) value chain, backed by sustained demand driven by rising prevalence of hormone-related conditions, increasing adoption of contraceptive therapies worldwide, growing clinical use in hormone replacement therapy, and expanding applications in oncology. As healthcare systems across developed and emerging economies…
Medroxyprogesterone Acetate Production Cost DPR & Unit Setup Report 2026
Setting up a medroxyprogesterone acetate (MPA) production plant positions investors in one of the most strategically important and rapidly expanding segments of the global pharmaceutical active ingredient value chain, backed by sustained demand driven by rising prevalence of gynecological disorders, growing awareness of reproductive health and family planning, expanding access to hormonal contraception across emerging markets, and increasing adoption of hormone replacement therapy as aging populations worldwide seek effective management…
Medroxyprogesterone Acetate Market, Advancing Women's Health Through Hormonal In …
Market Overview and Outlook
The global Medroxyprogesterone Acetate (MPA) Market continues to expand as pharmaceutical companies and healthcare providers rely on this synthetic progestin for a range of women's health applications. This increase is driven by rising awareness of reproductive health, expanding use in contraceptive therapies, and its role in hormone replacement therapy (HRT) for menopausal women.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a…
Global Medroxyprogesterone Acetate Market Imapct of AI and Automation
Medroxyprogesterone Acetate Market Impact of AI and Automation
The global Medroxyprogesterone Acetate (MPA) market was valued at approximately USD 1.2 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of around 5.8% from 2023 to 2030. This growth is driven by increasing awareness about contraceptive options, rising prevalence of hormone-related conditions, and expanding pharmaceutical applications. The market's upward trajectory reflects both a growing demand for hormonal…
Subcutaneous MedroxyProgesterone Acetate Market Analysis and Future Prospects fo …
The world of the subcutaneous medroxyprogesterone acetate market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing…
Global MedroxyProgesterone Market Forecast 2023-2028 Under Inflation
This MedroxyProgesterone market report provides a framework for big corporations to find the most profitable business opportunities. The COVID-19 caused substantial economic turmoil and uncertainty, resulting in increased market unpredictability. Additionally, in order to acquire very detailed data on segment and sub-segment, investigators must do significant research utilizing a regression approach. In-depth research is conducted by financial specialists using both bottom-up and top-down approaches.
Get Sample Copy of MedroxyProgesterone Market Report…
